Cargando…

Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study

BACKGROUND: Simultaneous treatment of moderate-to-severe upper facial lines is reflective of real-world clinical practice. OBJECTIVE: To evaluate the efficacy and safety of daxibotulinumtoxinA-lanm for injection (DAXI) for simultaneous treatment of glabellar, forehead, and lateral canthal (LC) lines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dover, Jeffrey S., Humphrey, Shannon D., Lorenc, Z. Paul, Shamban, Ava, Gross, Todd M., Rubio, Roman G., Vitarella, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760460/ https://www.ncbi.nlm.nih.gov/pubmed/36533798 http://dx.doi.org/10.1097/DSS.0000000000003637

Ejemplares similares

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
por: Green, Jeremy B., et al.
Publicado: (2021)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
por: Gallagher, Conor J., et al.
Publicado: (2023)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA
por: Dover, Jeffrey S., et al.
Publicado: (2023)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
por: Fabi, Sabrina G., et al.
Publicado: (2021)

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study
por: Jankovic, Joseph, et al.
Publicado: (2018)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
por: Glogau, Richard, et al.
Publicado: (2021)

Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
por: Solish, Nowell, et al.
Publicado: (2022)

Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2022)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
por: Carruthers, Jean D., et al.
Publicado: (2020)

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
por: Cohen, Joel L., et al.
Publicado: (2021)

Noninvasive Submental Fat Compartment Treatment
por: Shamban, Ava T.
Publicado: (2016)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies
por: Beer, Kenneth R., et al.
Publicado: (2019)

Upper eyelid blepharoplasty following hyaluronic acid injection with improved facial aesthetics and eye symptoms: a case report
por: Maione, Luca, et al.
Publicado: (2021)

Multimodal Facial Aesthetic Treatment on the Appearance of Aging, Social Confidence, and Psychological Well-being: HARMONY Study
por: Cohen, Joel L, et al.
Publicado: (2021)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study
por: Yun, Younghee, et al.
Publicado: (2013)

Upper facial chorea in Huntington disease
por: Fekete, Robert, et al.
Publicado: (2014)

Improved Patient Satisfaction With Skin After Treatment of Cheek Skin Roughness and Fine Lines With VYC-12L: Participant-Reported Outcomes From a Prospective, Randomized Study
por: Chiu, Annie, et al.
Publicado: (2023)

Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study
por: Villa-Muñoz, Paula, et al.
Publicado: (2023)

Facial Cushioning during Prolonged Surgery in the Upper Torso
por: Bank, Jonathan, et al.
Publicado: (2014)

High Yield Injection Targets and Danger Zones for Facial Filler Injection
por: Surek, Christopher C
Publicado: (2021)

The evidence for Shiatsu: a systematic review of Shiatsu and acupressure
por: Robinson, Nicola, et al.
Publicado: (2011)

MRI in detecting facial cosmetic injectable fillers
por: Tal, Sigal, et al.
Publicado: (2016)

Trends for Facial Injectable Therapies in Medical Aesthetics
por: Arsiwala, Shehnaz Z.
Publicado: (2018)

The Facial Shapes in Planning the Treatment with Injectable Fillers
por: Braz, André, et al.
Publicado: (2020)

Cerebral Hemorrhage after Cosmetic Facial Injection
por: Wang, Chenyu, et al.
Publicado: (2019)

Ultrasound as an Educational Tool in Facial Aesthetic Injections
por: Schelke, Leonie, et al.
Publicado: (2022)

P85. ARTIFICIALLY INTELLIGENT FACIAL FEATURE QUANTIFICATION AFTER FACIAL FILLER INJECTION
por: Desai, Abhishek A., et al.
Publicado: (2022)

The Genetic Profile from HLA and Non-HLA Loci Allows Identification of Atypical Type 2 Diabetes Patients
por: Fabregat, Matias, et al.
Publicado: (2015)

Labeling images with facial emotion and the potential for pediatric healthcare
por: Kalantarian, Haik, et al.
Publicado: (2019)

Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo
por: Schienle, Anne, et al.
Publicado: (2022)

Application of a Customized Cutting Guide for Upper Facial Feminization
por: Kapoor, Elina, et al.
Publicado: (2020)

Immunological reaction after facial hyaluronic acid injection
por: Homsy, Antoine, et al.
Publicado: (2017)

Persistent Facial Blanching after Botulinum Toxin Injection
por: Mitri, Fouad, et al.
Publicado: (2022)

Facial fillers: Relevant anatomy, injection techniques, and complications
por: Clark, Nicholas W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mqc6obve8r49naar2282c4i9l0